Tower Research Capital LLC (Trc) Care Dx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Care Dx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,448 shares of CDNA stock, worth $61,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,448
Previous 3,922
12.09%
Holding current value
$61,167
Previous $83,000
26.51%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CDNA
# of Institutions
230Shares Held
56.8MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$93.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$85.8 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$47.3 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$44.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$41.6 Million0.45% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $948M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...